Honasa Consumer Limited — Investor Meet, 19-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Honasa Consumer reported a revenue of INR 500 crores for the quarter, with a decline attributed mainly to the Mamaearth brand. While overall growth is impacted, younger brands like The Derma Co have shown solid growth, contributing over 40% of total revenue, with a year-to-date increase of more than 30%. The company's EBITDA margin contracted to 5%, primarily due to increased marketing expenditure aimed at brand revitalization.

2. **Future Outlook and Growth Drivers**: Management indicated a strategic shift aimed at scaling new distribution relationships and improving brand performance, particularly for Mamaearth, through enhanced product and media strategies. Despite current challenges, the focus remains on gaining market share and expanding brand presence.

3. **Order Book and Operational Updates**: The company has successfully appointed over 150 distributors in the top 50 cities in the last 6 to 7 months. This new distribution network is expected to contribute positively in subsequent quarters.

4. **Analyst Q&A Insights (Detailed)**:

- **Revenue and Profitability**: Analysts probed the company's declining sales, with management attributing most issues to internal transitions rather than broader market demand.

- **Market Position and Competitive Landscape**: Management expressed confidence in future market positioning despite heightened competitive pressures from emerging brands.

- **Operational Challenges or Risks**: The inventory correction process is ongoing, which management believes will stabilize in upcoming quarters.

- **Capex and Capital Allocation**: Increased marketing expenditures are planned for the coming quarter, with a return to normalized spending expected thereafter.

- **Strategic Priorities and Long-Term Vision**: Long-term goals remain robust, with aspirations to reach revenues of INR 4,000 crores by the end of the decade and aim for double-digit margins.

5. **Market or Regulatory Updates**: No major regulatory changes or market shifts were reported that might impact the company's strategy.

6. **Strategic Focus Areas**: Management emphasized a focus on distribution strength, brand optimization, and strategic partnerships, indicating a deliberate effort to enhance operational effectiveness and market share.

7. **Investor Insight**: The financial health and growth trajectory, coupled with strategic initiatives, suggest a 'buy' position for investors, despite the current market headwinds and operational challenges. The management's focus on long-term market share gains presents potential reopening opportunities.